(Q34293053)

1 August 2017

1 reference

title

Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma (English)

1 reference

1 August 2017

1 reference

1 reference

A A Sandberg

1

1 reference

1 August 2017

J A Bridge

series ordinal

2

1 reference

1 August 2017

publication date

1 June 2001

1 reference

Cancer Genetics and Cytogenetics

1 August 2017

published in

1 reference

1 August 2017

volume

127

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

93-110

1 reference

Phase II study of vinorelbine in patients with malignant pleural mesothelioma

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

The European mesothelioma epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Analysis of current trends in United States mesothelioma incidence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

The separation of benign and malignant mesothelial proliferations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Severe chromosomal aberrations in pleural mesotheliomas with unusual mesodermal features. Comparative genomic hybridization evidence for a mesothelioma subgroup.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

High levels of MDM2 are not correlated with the presence of wild-type p53 in human malignant mesothelioma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Asbestos: scientific developments and implications for public policy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Malignant mesothelioma: attributable risk of asbestos exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 status.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Malignant mesothelioma: clinical characteristics, asbestos mineralogy and chromosomal abnormalities of 41 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Crocidolite asbestos induces apoptosis of pleural mesothelial cells: role of reactive oxygen species and poly(ADP-ribosyl) polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Asbestos and mesothelioma: genetic lessons from a tragedy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

The molecular basis of asbestos induced lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Deletion mapping of the short arm of chromosome 3 in human malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: possible sites of tumor suppressor genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Cytogenetic analysis of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Molecular deletion of 9p sequences in non-small cell lung cancer and malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

del(6q) as a possible primary change in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Translocation (3;3)(p14;q29) as the Primary Chromosome Abnormality in a Peritoneal Mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Translocation X;12 in mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Chromosome changes in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Interphase cytogenetics on paraffin sections of malignant pleural mesothelioma. A comparison to conventional karyotyping and flow cytometric studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Detection of numerical chromosomal aberrations in paraffin-embedded malignant pleural mesothelioma by non-isotopic in situ hybridization.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Comparative genomic hybridization study on pooled DNAs from tumors of one clinical-pathological entity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Loss of heterozygosity analysis of 13q and 14q in human malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Rates of p16 (MTS1) mutations in primary tumors with 9p loss

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Open questions on p16

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Absence of p53 mutations in malignant mesotheliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

p53 expression is common in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

The frequency of p53 immunostaining in asbestos-associated mesotheliomas and non-asbestos-associated mesotheliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Physical and functional interaction between WT1 and p53 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

New molecular and epidemiological issues in mesothelioma: role of SV40.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Cell and molecular biology of simian virus 40: implications for human infections and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Susceptibility of p53-deficient mice to induction of mesothelioma by crocidolite asbestos fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

An old acquaintance resurfaces in human mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Mutations of p53 gene and SV40 sequences in asbestos associated and non-asbestos-associated mesotheliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Simian virus 40, poliovaccines and human tumors: a review of recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Simian virus 40 and human pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Loss of heterozygosity on the short arm of chromosome 3 in mesothelioma cell lines and solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Gap junctional intercellular communication of primary and asbestos-associated malignant human mesothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Expression of cell adhesion molecules and connexins in gap junctional intercellular communication deficient human mesothelioma tumour cell lines and communication competent primary mesothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Regional assignment of seven loci to 12p13.2-pter by PCR analysis of somatic cell hybrids containing the der(12) or the der(X) chromosome from a mesothelioma showing t(X;12)(q22;p13).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

A physical map of the region spanning the chromosome 12 translocation breakpoint in a mesothelioma with a t(X;12)(q22;p13)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Mitotic and in situ end-labeling apoptotic indices as prognostic markers in malignant mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Absence of BCL10 mutations in human malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Absence of HHV-8 DNA sequences in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Expression of E-cadherin in bone and soft tissue sarcomas: a possible role in epithelial differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Prognostic significance of DNA aneuploidy in diffuse malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Translocation (2;3)(p21;p26) as the sole anomaly in a benign localized fibrous mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

The search for the optimal immunohistochemical panel for the diagnosis of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

N-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas: a ThinPrep immunocytochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Calretinin: A Novel Immunocytochemical Marker for Mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma: utility of combined E-cadherin and calretinin immunostaining

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

The immunohistochemical diagnosis of epithelial mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Nonrandom chromosomal abnormalities in malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Emerging translational therapies for mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Chromosomes and chromosomal evolution in human mesotheliomas as reflected in sequential analyses of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Karyotypic changes in the preclinical and subsequent stages of malignant mesothelioma: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

DNA copy number changes in familial malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor beta-integrin alpha3beta1 interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Differential motile response of human malignant mesothelioma cells to fibronectin, laminin and collagen type IV: the role of beta1 integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Tenascin and fibronectin expression in human mesothelial cells and pleural mesothelioma cell-line cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Gene expression profiling of malignant mesothelioma cell lines: cDNA array study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Heterogeneity of mesothelioma cell lines as defined by altered genomic structure and expression of the NF2 gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Absence of post-transcriptional RNA modifications of BCL10 in human malignant mesothelioma and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Control of cell cycle progression in human mesothelioma cells treated with gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Benign and malignant mesothelial proliferations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

Expression and prognostic significance of catalase in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900432-0

7 January 2021

10.1016/S0165-4608(01)00432-0

Identifiers

DOI

1 reference

1 August 2017

1 reference